Regulation of P450 4A expression by peroxisome proliferator activated receptors

Toxicology

Volumn 181-182, Issue , 2002, Pages 203-206

  Johnson, Eric F ^a   Hsu, Mei Hui ^a   Savas, Uzen ^a   Griffin, Keith J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CYP4A; Fatty acid oxidation; Gene regulation; Ketogenesis; Peroxisome proliferation; Peroxisome proliferator activated receptor, PPAR

Indexed keywords

CELL NUCLEUS RECEPTOR; CYTOCHROME P450 4A; DIMER; FATTY ACID; KETONE BODY; NUCLEOTIDE; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RETINOID X RECEPTOR;

AMINO ACID SEQUENCE; AT RICH SEQUENCE; CELL CULTURE; CELL STRAIN HEPG2; DNA RESPONSIVE ELEMENT; ENZYME REGULATION; FATTY ACID OXIDATION; GENE TARGETING; GENETIC CODE; GENETIC ENGINEERING; GENETIC VARIABILITY; HEPATOMEGALY; HUMAN; LIVER CARCINOGENESIS; LIVER HYPERPLASIA; LONG TERM EXPOSURE; MEDIATOR; NONHUMAN; NUCLEOTIDE REPEAT; PATHOGENESIS; PEROXISOME; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SPECIES DIFFERENCE;

EID: 0037184821     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00282-2     Document Type: Article

References (19)

1. Aldridge T.C., Tugwood J.D., Green S. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 306:1995;473-479.
2. Aoyama T., Peters J.M., Iritani N., Nakajima T., Furihata K., Hashimoto T., Gonzalez F.J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J. Biol. Chem. 273:1998;5678-5684.
3. Bell A.R., Savory R., Horley N.J., Choudhury A.I., Dickins M., Gray T.J., Salter A.M., Bell D.R. Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia. Biochem. J. 332:1998;689-693.
4. Cattley R.C., DeLuca J., Elcombe C., Fenner-Crisp P., Lake B.G., Marsman D.S., Pastoor T.A., Popp J.A., Robinson D.E., Schwetz B., Tugwood J., Wahli W. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regul. Toxicol. Pharmacol. 27:1998;47-60.
5. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20:1999;649-688.
6. Hsu M.-H., Savas U., Griffin K.J., Johnson E.F. Identification of peroxisome proliferator responsive human genes by elevated expression of the peroxisome proliferator activated receptor alpha (PPARα) in HepG2 cells. J. Biol. Chem. 276:2001;27950-27958.
7. Hsu M.H., Palmer C.N.A., Song W., Griffin K.J., Johnson E.F. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. J. Biol. Chem. 273:1998;27988-27997.
8. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103:1999;1489-1498.
9. Le Maya C., Pineaub T., Bigotb K., Kohla C., Girarda J., Pegoriera J.P. Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression. FEBS Lett. 475:2000;163-166.
10. Lee S.S.T., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., Gonzalez F.J. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:1995;3012-3022.
11. Leone T.C., Weinheimer C.J., Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA. 96:1999;7473-7478.
12. Macdonald N., Holden P.R., Roberts R.A. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators. Cancer Res. 59:1999;4776-4780.
13. Muerhoff A.S., Griffin K.J., Johnson E.F. The peroxisome proliferator activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J. Biol. Chem. 267:1992;19051-19053.
14. Palmer C.N.A., Hsu M.-H., Griffin K.J., Johnson E.F. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270:1995;16114-16121.
15. Palmer C.N.A., Hsu M.-H., Muerhoff A.S., Griffin K.J., Johnson E.F. Interaction of the peroxisome proliferator-activated receptor α with the retinoid X receptor α unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter. J. Biol. Chem. 269:1994;18083-18089.
16. Palmer C.N.A., Hsu M.H., Griffin K.J., Raucy J.L., Johnson E.F. Peroxisome proliferator activated receptor-α expression in human liver. Mol. Pharmacol. 53:1998;14-22.
17. Peters J.M., Cattley R.C., Gonzalez F.J. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis. 18:1997;2029-2033.
18. Reddy J.K., Mannaerts G.P. Peroxisomal lipid metabolism. Annu. Rev. Nutr. 14:1994;343-370.
19. Singh I. Biochemistry of peroxisomes in health and disease. Mol. Cell. Biochem. 167:1997;1-29.